Stocks

Tandem Diabetes Care TNDM

Health care sectorNasdaq

What to see in Tandem Diabetes Care now

Who bought more than 5%?0.2%

Voya Financial holds 0.2% · −6.1pp on the report before

Filed 08/06
Is Wall Street adding or cutting?+1

274 13F filers hold it · +1 against the quarter before · shares held +0.2%

Holdings of 06/30
Is stock about to come to market?$6,311

$6,311 of planned sales filed in 30 days · under 0.1% of the units outstanding

Filed 09/17

Company

Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
San Diego, California
Fiscal year end
12/31
Next earnings
11/06, estimated
  • $6,311 of planned sales filed in 30 days · under 0.1% of the units outstandingFiled 09/17

Insider trades

Trade type
Mark David NovaraEVP & CHIEF COMMERCIAL OFFICER
Open-market sale03/1703/18187 sh$23.05$4,310.35−0.5%
Mark David NovaraEVP & CHIEF COMMERCIAL OFFICER
Open-market sale10b5-1 plan03/0503/092 sh$22.81$45.62−0.0%
John F. SheridanPRESIDENT & CEO
Open-market buy25/08/1125/08/1110,000 sh$10.23$102,300+10.4%
Leigh VossellerEVP & CHIEF FINANCIAL OFFICER
Open-market buy25/08/0825/08/1113,720 sh$10.89$149,410.8+115.7%
Jean-Claude KyrillosEVP & Chief Operating Officer
Open-market buy25/03/0725/03/1110,538 sh$18.12$190,948.56No record
All insider trades in Tandem Diabetes Care

Planned sales

Tandem Diabetes CareTNDM10b5-1 plan
360 sh$6,310.809/17Filed 09/17
Tandem Diabetes CareTNDM10b5-1 plan
131 sh$2,915.4108/18Filed 08/18
Tandem Diabetes CareTNDM10b5-1 plan
361 sh$6,025.0906/17Filed 06/17
Tandem Diabetes CareTNDM10b5-1 plan
266 sh$3,598.9805/19Filed 05/19
Tandem Diabetes CareTNDM10b5-1 plan
187 sh$4,097.1703/17Filed 03/17
Tandem Diabetes CareTNDM10b5-1 plan
2 sh$46.8203/05Filed 03/05
All planned sales of Tandem Diabetes Care

26-week trading

Common questions

Which members of Congress traded Tandem Diabetes Care TNDM recently?
The latest reported trades: Rep. Gilbert Cisneros, purchase on 03/03 (reported 04/07).